Style | Citing Format |
---|---|
MLA | E Daliri ELMIRA, et al.. "Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780))." European Journal of Pharmacology, vol. 1003, no. , 2025, pp. -. |
APA | E Daliri ELMIRA, Z Hamyani ZAHRA, A Arjangi ALI, F Khakpai FATEMEH, S Alijanpour SAKINEH, Mr Zarrindast Mohammad REZA (2025). Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780)). European Journal of Pharmacology, 1003(), -. |
Chicago | E Daliri ELMIRA, Z Hamyani ZAHRA, A Arjangi ALI, F Khakpai FATEMEH, S Alijanpour SAKINEH, Mr Zarrindast Mohammad REZA. "Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780))." European Journal of Pharmacology 1003, no. (2025): -. |
Harvard | E Daliri ELMIRA et al. (2025) 'Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780))', European Journal of Pharmacology, 1003(), pp. -. |
Vancouver | E Daliri ELMIRA, Z Hamyani ZAHRA, A Arjangi ALI, F Khakpai FATEMEH, S Alijanpour SAKINEH, Mr Zarrindast Mohammad REZA. Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780)). European Journal of Pharmacology. 2025;1003():-. |
BibTex | @article{ author = {E Daliri ELMIRA and Z Hamyani ZAHRA and A Arjangi ALI and F Khakpai FATEMEH and S Alijanpour SAKINEH and Mr Zarrindast Mohammad REZA}, title = {Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780))}, journal = {European Journal of Pharmacology}, volume = {1003}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - E Daliri ELMIRA AU - Z Hamyani ZAHRA AU - A Arjangi ALI AU - F Khakpai FATEMEH AU - S Alijanpour SAKINEH AU - Mr Zarrindast Mohammad REZA TI - Corrigendum to “Combination Therapy With Citalopram, Bupropion, and Lithium for the Amelioration of the Depressive-Related Effects Induced by Dexamethasone in Male Mice” [Eur. J. Pharmacol. 1002 (2025) 177780] (European Journal of Pharmacology (2025) 1002, (S0014299925005345), (10.1016/J.Ejphar.2025.177780)) JO - European Journal of Pharmacology VL - 1003 IS - SP - EP - PY - 2025 ER - |